Arrowhead Pharmaceuticals Inc.

ARWR | NASDAQ

Price Alert Chart Builder DCF Calculator

$71.57

+$2.78 (+4.04%)

Sep 22, 2026, 12:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
Cash & Equivalents	226.55M	102.69M	110.89M	108.01M	184.43M	143.58M
Short-Term Investments	692.82M	578.28M	292.74M	268.39M	183.36M	171.91M
Long-Term Investments	n/a	n/a	n/a	105.87M	245.6M	137.49M
Other Long-Term Assets	1.39M	4.48M	210K	218K	272K	265.36K
Receivables	6.82M	n/a	n/a	1.41M	10.26M	845.67K
Inventory	n/a	n/a	n/a	-21.61M	4.36M	4.25M
Other Current Assets	13.52M	4.97M	7.08M	41.82M	-2.17M	-2.47M
Total Current Assets	950.64M	695.47M	419.52M	405.3M	384.6M	322.37M
Property-Plant & Equipment	426.41M	431.29M	335.56M	168.59M	66.02M	47.02M
Goodwill & Intangibles	6.86M	8.56M	10.26M	11.96M	13.66M	15.36M
Total Long-Term Assets	434.66M	444.33M	346.03M	286.64M	325.55M	200.13M
Total Assets	1.39B	1.14B	765.55M	691.94M	710.15M	522.5M
Account Payables	17.67M	11.39M	35.87M	2.87M	9.46M	6.83M
Deferred Revenue	2.4M	n/a	866K	74.1M	111.06M	19.29M
Short-Term Debt	40M	6.34M	10.56M	2.78M	2.25M	1.09M
Other Current Liabilities	80.43M	63.45M	40.2M	46.86M	14M	5.41M
Total Current Liabilities	195.49M	103.17M	105.46M	138.85M	146.54M	40.68M
Long-Term Debt	214.88M	734.54M	268.33M	n/a	n/a	n/a
Other Long-Term Liabilities	367.4M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	686.39M	845.57M	372.93M	134.75M	154.79M	20.04M
Total Liabilities	881.88M	948.74M	478.39M	273.6M	301.33M	60.72M
Total Debt	366.28M	851.91M	383.5M	81.58M	25.55M	21.14M
Book Value	503.42M	191.06M	287.16M	418.34M	408.82M	461.78M
Book Value Per Share	3.76	1.60	2.69	3.97	3.94	4.58
Common Stock	231K	217K	200K	198K	197K	194.75K
Retained Earnings	-1.63B	-1.63B	-1.03B	-820.76M	-644.69M	-503.84M
Comprehensive Income	6.44M	4.75M	-3.22M	-136K	-69K	18.43K
Shareholders Equity	466.05M	185.44M	271.34M	398.52M	408.82M	461.78M
Total Investments	692.82M	578.28M	292.74M	374.26M	428.95M	309.4M